Affinage

DDX43

Probable ATP-dependent RNA helicase DDX43 · UniProt Q9NXZ2

Length
648 aa
Mass
72.8 kDa
Annotated
2026-04-28
26 papers in source corpus 10 papers cited in narrative 10 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DDX43 (HAGE) is an ATP-dependent DEAD-box helicase that couples an N-terminal K-homology (KH) domain to a C-terminal helicase core to unwind both RNA and DNA substrates, thereby regulating mRNA translation, chromatin remodeling, and antiviral defense. The KH domain binds pyrimidine-rich single-stranded nucleic acids (preferring TTGT/UUGU motifs) and is indispensable for full ATPase and unwinding activity; physical connectivity of all domains—KH, linker, and helicase core—is required for high-affinity substrate engagement (PMID:28468824, PMID:33199368, PMID:31623828). In cancer cells, DDX43 unwinds NRAS and SOCS1 mRNAs to promote their translation, activating RAS–ERK–AKT signaling and suppressing JAK–STAT-mediated interferon responses, which collectively drive tumor-initiating cell survival and drug resistance (PMID:22393060, PMID:24525737, PMID:24899684). In the male germline, DDX43 ATPase activity is essential for histone-to-protamine replacement during spermiogenesis—knockout or ATPase-dead knock-in mice are infertile with chromatin condensation defects—and DDX43 additionally functions as an interferon-independent host restriction factor against HSV-2 (PMID:37120627, PMID:41157636).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2012 High

    The first mechanistic link between DDX43 and a specific mRNA target was established when HAGE was shown to unwind NRAS mRNA, thereby controlling NRAS protein levels and downstream RAS–ERK–AKT signaling required for melanoma-initiating cell tumor growth.

    Evidence shRNA knockdown, siRNA rescue, in vitro unwinding assay, xenograft transplantation in NOD/SCID mice

    PMID:22393060

    Open questions at the time
    • Structural basis for DDX43 recognition of NRAS mRNA was unknown
    • Whether DDX43 unwinds NRAS mRNA secondary structure or displaces bound proteins was not distinguished
    • Generalizability to other RAS family mRNAs was untested
  2. 2014 High

    DDX43's target repertoire was extended to SOCS1 mRNA, revealing how HAGE suppresses JAK–STAT signaling and interferon-induced PML expression in melanoma-initiating cells, and separately, how DDX43 overexpression drives MEK inhibitor resistance by upregulating multiple RAS proteins in uveal melanoma.

    Evidence shRNA/siRNA knockdown and rescue for SOCS1; ectopic overexpression and depletion with pathway readouts for RAS/ERK/AKT in MEK-resistant cells

    PMID:24525737 PMID:24899684

    Open questions at the time
    • Direct binding of DDX43 to SOCS1 mRNA was inferred from unwinding assays but not mapped at nucleotide resolution
    • Whether DDX43 acts co-transcriptionally or post-transcriptionally on these targets was not resolved
  3. 2017 High

    Biochemical reconstitution revealed DDX43 as a dual RNA/DNA helicase with opposite polarity on the two substrates (5′→3′ on RNA, 3′→5′ on DNA), and identified the N-terminal KH domain as indispensable for nucleic acid binding and unwinding.

    Evidence Recombinant protein purification, in vitro helicase assay with truncation and site-directed mutagenesis

    PMID:28468824

    Open questions at the time
    • Why DDX43 displays opposite directionality on RNA versus DNA was mechanistically unexplained
    • Whether DNA helicase activity is physiologically relevant was unclear
  4. 2019 Medium

    Domain dissection showed DDX43 functions as a monomer and that physical connectivity of all three domains (KH, linker, helicase core) is required for high-affinity nucleic acid binding, explaining why isolated domains are insufficient.

    Evidence Recombinant protein purification, EMSA with domain truncation and disconnection constructs

    PMID:31623828

    Open questions at the time
    • No high-resolution structure of the full-length protein to explain inter-domain communication
    • Role of the flexible linker beyond physical connectivity was not characterized
  5. 2020 High

    The KH domain's substrate specificity was defined: it preferentially recognizes pyrimidine-rich TTGT/UUGU motifs via its GXXG loop, conferring sequence-selective unwinding to the full-length helicase.

    Evidence SELEX, NMR (¹⁵N-HSQC), EMSA, ChIP-seq, CLIP-seq, mutational analysis

    PMID:33199368

    Open questions at the time
    • Genome-wide identification of physiological RNA targets bearing UUGU motifs was not completed
    • Whether KH-mediated specificity explains selective unwinding of NRAS/SOCS1 mRNAs was not tested
  6. 2023 High

    A physiological in vivo role was established: DDX43 is essential for spermiogenesis, where its ATPase activity drives histone-to-protamine replacement; an ATPase-dead knock-in phenocopied full knockout infertility, and eCLIP identified Elfn2 as a direct RNA target in spermatids.

    Evidence Testis-specific and global Ddx43 knockout mice, ATPase-dead knock-in, single-cell RNA-seq, eCLIP-seq

    PMID:37120627

    Open questions at the time
    • How DDX43 unwinding of target mRNAs like Elfn2 mechanistically triggers chromatin remodeling remains unknown
    • Whether DDX43 participates in piRNA amplification in vivo (as suggested by homology) was not directly tested
  7. 2025 Medium

    DDX43 was identified as a host antiviral factor that restricts HSV-2 replication independently of the interferon response, broadening its functional repertoire beyond oncogenesis and gametogenesis.

    Evidence Overexpression and siRNA knockdown in HeLa and ARPE-19 cells, viral replication assays

    PMID:41157636

    Open questions at the time
    • The viral RNA or DNA target(s) of DDX43 during HSV-2 restriction were not identified
    • Whether antiviral activity depends on the KH domain or helicase activity specifically was not tested
    • Generalizability to other DNA or RNA viruses is unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • A full-length atomic structure of DDX43, genome-wide mapping of its physiological mRNA targets in somatic and germline cells, and the mechanism by which mRNA unwinding couples to translational activation or chromatin remodeling remain unresolved.
  • No full-length crystal or cryo-EM structure exists
  • Transcriptome-wide target identification in cancer cells has not been performed
  • Mechanism linking mRNA unwinding to translational promotion is not defined

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0003677 DNA binding 3 GO:0003723 RNA binding 3 GO:0140098 catalytic activity, acting on RNA 3 GO:0140657 ATP-dependent activity 2
Localization
GO:0005634 nucleus 1
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-1474165 Reproduction 1 R-HSA-168256 Immune System 1
Partners

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2017 DDX43 is an ATP-dependent dual RNA and DNA helicase containing a K-homology (KH) domain in its N-terminus that is required for full nucleic acid unwinding activity. It shows 5' to 3' polarity on RNA and 3' to 5' directionality on DNA. The KH domain is responsible for nucleic acid binding, and without it the C-terminal helicase domain alone shows no RNA unwinding and significantly reduced DNA unwinding activity. Single amino acid changes in the KH domain reduce both binding and unwinding activities. Recombinant protein purification, in vitro helicase assay, truncation mutations, site-directed mutagenesis The Journal of biological chemistry High 28468824
2020 The KH domain of DDX43 preferentially binds pyrimidine-rich ssDNA and ssRNA (favoring TTGT/UUGU sequences), with the GXXG loop and an adjacent alanine residue critical for pyrimidine binding. The KH domain facilitates substrate specificity and unwinding processivity of the full-length DDX43 helicase, and DDX43 prefers substrates with TTGT/UUGU single-stranded tails. EMSA, NMR (15N-HSQC), SELEX, ChIP-seq, CLIP-seq, bioinformatics, mutational analysis The Journal of biological chemistry High 33199368
2012 DDX43/HAGE is required for ABCB5+ malignant melanoma-initiating cell (MMIC)-dependent tumor growth. Knockdown of HAGE decreases NRAS protein expression with concomitant decrease in AKT and ERK pathway activation. HAGE promotes NRAS mRNA unwinding in vitro, and NRAS silenced by siRNA can be rescued by HAGE reintroduction, demonstrating that NRAS expression is dependent on HAGE helicase activity. shRNA knockdown, in vitro helicase/unwinding assay, siRNA rescue experiment, xenograft tumor transplantation in NOD/SCID mice The Journal of biological chemistry High 22393060
2014 DDX43/HAGE prevents IFN-α-induced PML expression in ABCB5+ MMICs by promoting SOCS1 mRNA unwinding and protein expression, thereby inhibiting JAK-STAT pathway activation. Knockdown of HAGE decreases SOCS1 protein expression, activates JAK-STAT signaling, and increases PML expression. SOCS1 silenced by siRNA can be rescued by reintroduction of HAGE, confirming SOCS1 expression is dependent on HAGE helicase activity. shRNA knockdown, siRNA rescue, in vitro unwinding assay, stem cell proliferation assay, xenotransplantation assay Cell death & disease High 24525737
2014 DDX43 overexpression in MEK inhibitor-resistant uveal melanoma cells induces RAS protein levels (KRAS, HRAS, NRAS) and activates ERK and AKT pathways, mediating MEK inhibitor resistance. Depletion of DDX43 decreases RAS proteins and inhibits downstream signaling, while ectopic DDX43 expression in parental cells renders them resistant to MEK inhibition. shRNA/siRNA knockdown, ectopic overexpression, Western blot for RAS/ERK/AKT pathway activation, cell viability assays Molecular cancer therapeutics Medium 24899684
2018 DDX43 in CML promotes cell survival and tumorigenesis by arresting miR-186 (which normally targets DDX43) and releasing/upregulating lncRNA H19 through promoter demethylation. miR-186 targets DDX43 mRNA directly, and overexpression of miR-186 increases apoptosis. Silencing H19 inhibits cell survival. Overexpression and knockdown of DDX43, miRNA transfection, colony formation assay, apoptosis assay, methylation analysis Oncogene Medium 29449695
2023 DDX43 is an essential regulator of chromatin remodeling during spermiogenesis. Testis-specific Ddx43 knockout mice are infertile with defective histone-to-protamine replacement and post-meiotic chromatin condensation defects. Loss of ATP hydrolysis activity (ATPase-dead missense mutation) replicates the infertility phenotype, indicating dependence on enzymatic activity. DDX43 regulates dynamic RNA regulatory processes in spermatids and targets the hub gene Elfn2, identified by eCLIP-seq. Testis-specific knockout mice, global knockout mice, ATPase-dead knock-in missense mutation, single-cell RNA-seq, eCLIP-seq, phenotypic analysis of spermatogenesis Nature communications High 37120627
2019 DDX43 exists as a homogeneous monomer in solution and preferentially binds single-stranded DNA or RNA substrates longer than 12 nt, with preference for guanosine. Full binding affinity requires physical connectivity of all domains (KH, linker, and helicase core); removal or disconnection of any domain reduces binding affinity approximately 10-fold. Recombinant protein purification from E. coli, EMSA, domain truncation and disconnection experiments Biochemical and biophysical research communications Medium 31623828
2022 DDX43 domain architecture comprises an N-terminal KH domain, a central flexible linker domain, and a C-terminal helicase core domain. The KH domain is required for ATPase and unwinding activity. DDX43 has documented roles in piRNA amplification, tumorigenesis, RAS signaling, and innate immunity. Biochemical structure-function review integrating EMSA, SELEX, ChIP-seq, CLIP-seq, NMR, and cellular studies Methods (San Diego, Calif.) Medium 35257897
2025 DDX43 inhibits HSV-2 replication in an interferon-independent manner. Overexpression of DDX43 inhibited HSV-2 replication while knockdown of endogenous DDX43 enhanced it, establishing DDX43 as a host restriction factor against HSV-2. Overexpression and siRNA knockdown in HeLa and ARPE-19 cells, viral replication assays, comparative transcriptomics/OPLS-DA Viruses Medium 41157636

Source papers

Stage 0 corpus · 26 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia 68 12399967
2007 Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia. Haematologica 44 17296563
2010 HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers. Cancer immunity 36 20058853
2023 Single-cell RNA-seq uncovers dynamic processes orchestrated by RNA-binding protein DDX43 in chromatin remodeling during spermiogenesis. Nature communications 35 37120627
2017 The DEAD-box protein DDX43 (HAGE) is a dual RNA-DNA helicase and has a K-homology domain required for full nucleic acid unwinding activity. The Journal of biological chemistry 33 28468824
2012 The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo. The Journal of biological chemistry 32 22393060
2012 Hydroxybutyrate prevents protein aggregation in the halotolerant bacterium Pseudomonas sp. CT13 under abiotic stress. Extremophiles : life under extreme conditions 32 22527039
2014 Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells. Molecular cancer therapeutics 26 24899684
2007 HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer immunology, immunotherapy : CII 24 17487488
2020 The KH domain facilitates the substrate specificity and unwinding processivity of DDX43 helicase. The Journal of biological chemistry 22 33199368
2018 Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression. Oncogene 22 29449695
2003 Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands. Molecular pathology : MP 21 12890744
2014 DDX43 promoter is frequently hypomethylated and may predict a favorable outcome in acute myeloid leukemia. Leukemia research 17 24656837
2014 The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1. Cell death & disease 16 24525737
2022 DDX43 recruits TRIF or IPS-1 as an adaptor and activates the IFN-β pathway in Nile tilapia (Oreochromis niloticus). Molecular immunology 10 34990938
2022 Structure-function analysis of DEAD-box helicase DDX43. Methods (San Diego, Calif.) 9 35257897
2021 A Novel HAGE/WT1-ImmunoBody® Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone. Frontiers in oncology 7 34262856
2019 DDX43 prefers single strand substrate and its full binding activity requires physical connection of all domains. Biochemical and biophysical research communications 7 31623828
2013 The methylation status of the DDX43 promoter in Chinese patients with chronic myeloid leukemia. Genetic testing and molecular biomarkers 7 23495895
2017 Expression and significance of DDX43 in lung adenocarcinoma. Pakistan journal of pharmaceutical sciences 6 29044003
2021 Helicase antigen (HAGE)-derived vaccines induce immunity to HAGE and ImmunoBody®-HAGE DNA vaccine delays the growth and metastasis of HAGE-expressing tumors in vivo. Immunology and cell biology 5 34105800
2023 DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer. PloS one 4 37200388
2021 Modification of the multiplex plasmid PCR assay for Borrelia miyamotoi strain LB-2001 based on the complete genome sequence reflecting genomic rearrangements differing from strain CT13-2396. Ticks and tick-borne diseases 3 34656944
2025 Comparative Transcriptomics Analyses Identify DDX43 as a Cellular Regulator Involved in Suppressing HSV-2 Replication. Viruses 1 41157636
2024 Effect of DNMT3A R882H Hot Spot Mutations on DDX43 Promoter Methylation in Acute Myeloid Leukemia. BioMed research international 0 38807916
2024 Correction: DDX43 mRNA expression and protein levels in relation to clinicopathological profile of breast cancer. PloS one 0 39724251